Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Condition(s):Warm Autoimmune Hemolytic AnemiaLast Updated:June 28, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Warm Autoimmune Hemolytic AnemiaLast Updated:June 28, 2023Not yet recruiting
Condition(s):Diffuse Large B-cell Lymphoma(DLBCL)Last Updated:February 28, 2022Recruiting
Condition(s):Neuromyelitis OpticaLast Updated:May 20, 2022Recruiting
Condition(s):Immune Thrombocytopenia; TreatmentLast Updated:January 28, 2022Recruiting
Condition(s):Antiphospholipid Syndrome; Thrombocytopenia; TreatmentLast Updated:January 26, 2023Recruiting
Condition(s):Waldenstrom MacroglobulinemiaLast Updated:June 22, 2023Recruiting
Condition(s):IgG4 Related DiseaseLast Updated:November 22, 2023Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:February 13, 2024Not yet recruiting
Condition(s):Diffuse Large B-cell Lymphoma (DLBCL)Last Updated:October 27, 2022Not yet recruiting
Condition(s):Marginal Zone Lymphoma; MZLLast Updated:June 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.